Cargando…
Lysosomal Destabilizing Drug Siramesine and the Dual Tyrosine Kinase Inhibitor Lapatinib Induce a Synergistic Ferroptosis through Reduced Heme Oxygenase-1 (HO-1) Levels
Ferroptosis is an iron-dependent type of cell death distinct from apoptosis or necrosis characterized by accumulation of reactive oxygen species. The combination of siramesine, a lysosomotropic agent, and lapatinib, a dual tyrosine kinase inhibitor (TKI), synergistically induced cell death in breast...
Autores principales: | Villalpando-Rodriguez, Gloria E., Blankstein, Anna R., Konzelman, Carmen, Gibson, Spencer B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766165/ https://www.ncbi.nlm.nih.gov/pubmed/31636810 http://dx.doi.org/10.1155/2019/9561281 |
Ejemplares similares
-
Ferroptosis and autophagy induced cell death occur independently after siramesine and lapatinib treatment in breast cancer cells
por: Ma, Shumei, et al.
Publicado: (2017) -
Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells
por: Ma, S, et al.
Publicado: (2016) -
Effects of the lysosomal destabilizing drug siramesine on glioblastoma in vitro and in vivo
por: Jensen, Stine S., et al.
Publicado: (2017) -
Siramesine triggers cell death through destabilisation of mitochondria, but not lysosomes
por: Hafner Česen, M, et al.
Publicado: (2013) -
Regulation of Complement Activation by Heme Oxygenase-1 (HO-1) in Kidney Injury
por: Detsika, Maria G., et al.
Publicado: (2021)